(XLV) Health Care Sector Fund - Overview
Exchange: NYSE ARCA •
Country: USA •
Currency: USD •
Type: Etf •
ISIN: US81369Y2090
Etf: Pharmaceuticals, Equipment, Providers, Biotechnology, Technology
Total Rating 36
Risk 72
Buy Signal -0.09
| Risk 5d forecast | |
|---|---|
| Volatility | 16.7% |
| Relative Tail Risk | -2.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -5.12 |
| Character TTM | |
|---|---|
| Beta | 0.393 |
| Beta Downside | 0.380 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.11% |
| CAGR/Max DD | 0.53 |
Description: XLV Health Care Sector Fund March 04, 2026
XLV is an exchange-traded fund (ETF) tracking a healthcare sector index. It primarily invests in the securities of that index, holding at least 95% of its assets in those components.
The funds holdings span diverse healthcare industries. These include pharmaceuticals, a sector focused on drug discovery and manufacturing, and biotechnology, which utilizes biological processes for product development. Other industries within the fund are healthcare equipment and supplies, healthcare providers and services, life sciences tools and services, and health care technology.
XLV is classified as non-diversified. Further research on ValueRay can provide more in-depth analysis of its holdings and performance.
Headlines to watch out for
- Pharmaceutical patent expirations impact drug manufacturer revenue
- Healthcare policy changes create regulatory uncertainty
- Medical device innovation drives sector growth
- Biotechnology breakthroughs boost investment sentiment
- Healthcare service demand increases with aging population
What is the price of XLV shares?
As of March 10, 2026, the stock is trading at USD 154.26 with a total of 18,670,696 shares traded.
Over the past week, the price has changed by -2.69%, over one month by -1.32%, over three months by +3.31% and over the past year by +6.30%.
Over the past week, the price has changed by -2.69%, over one month by -1.32%, over three months by +3.31% and over the past year by +6.30%.
Is XLV a buy, sell or hold?
Health Care Sector Fund has no consensus analysts rating.
What are the forecasts/targets for the XLV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |